B&G Foods (BGS) Competitors

B&G Foods (NYSE:BGS) and MEDIFAST (NYSE:MED) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

Does the media refer more to BGS or MED?

In the previous week, B&G Foods had 4 more articles in the media than MEDIFAST. MarketBeat recorded 4 mentions for B&G Foods and 0 mentions for MEDIFAST. MEDIFAST's average media sentiment score of 1.63 beat B&G Foods' score of -0.31 indicating that MEDIFAST is being referred to more favorably in the news media.

Company	Overall Sentiment
B&G Foods	Neutral
MEDIFAST	Very Positive

Is BGS or MED more profitable?

MEDIFAST has a net margin of -1.29% compared to B&G Foods' net margin of -11.16%. B&G Foods' return on equity of 7.00% beat MEDIFAST's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
B&G Foods	-11.16%	7.00%	1.41%
MEDIFAST	-1.29%	6.63%	4.81%

Which has preferable earnings and valuation, BGS or MED?

MEDIFAST has lower revenue, but higher earnings than B&G Foods. MEDIFAST is trading at a lower price-to-earnings ratio than B&G Foods, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
B&G Foods	$1.93B	0.17	-$251.25M	-$2.66	-1.53
MEDIFAST	$602.46M	0.24	$2.09M	-$0.65	-20.42

Which has more volatility & risk, BGS or MED?

B&G Foods has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Comparatively, MEDIFAST has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500.

Do analysts recommend BGS or MED?

B&G Foods presently has a consensus target price of $7.10, suggesting a potential upside of 74.45%. MEDIFAST has a consensus target price of $16.50, suggesting a potential upside of 24.34%. Given B&G Foods' higher probable upside, equities research analysts clearly believe B&G Foods is more favorable than MEDIFAST.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
B&G Foods	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
MEDIFAST	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Do insiders & institutionals hold more shares of BGS or MED?

66.2% of B&G Foods shares are held by institutional investors. Comparatively, 95.5% of MEDIFAST shares are held by institutional investors. 3.2% of B&G Foods shares are held by insiders. Comparatively, 2.9% of MEDIFAST shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

MEDIFAST beats B&G Foods on 9 of the 15 factors compared between the two stocks.